DK320276A - Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner - Google Patents
Fremgangsmade til fremstilling af 2-substituerede oxazolpyridinerInfo
- Publication number
- DK320276A DK320276A DK320276A DK320276A DK320276A DK 320276 A DK320276 A DK 320276A DK 320276 A DK320276 A DK 320276A DK 320276 A DK320276 A DK 320276A DK 320276 A DK320276 A DK 320276A
- Authority
- DK
- Denmark
- Prior art keywords
- pyridines
- procedure
- preparation
- substituted oxazole
- oxazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/72—Polycyclic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/600,169 US4011326A (en) | 1975-07-29 | 1975-07-29 | 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK320276A true DK320276A (da) | 1977-01-30 |
Family
ID=24402575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK320276A DK320276A (da) | 1975-07-29 | 1976-07-15 | Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4011326A (da) |
| JP (1) | JPS6037116B2 (da) |
| AU (1) | AU505159B2 (da) |
| BE (1) | BE844577A (da) |
| CH (1) | CH603661A5 (da) |
| DE (1) | DE2633905A1 (da) |
| DK (1) | DK320276A (da) |
| ES (1) | ES450245A1 (da) |
| FR (1) | FR2319354A1 (da) |
| GB (1) | GB1497985A (da) |
| HU (1) | HU172167B (da) |
| NL (1) | NL7607794A (da) |
| SE (1) | SE431545B (da) |
| ZA (1) | ZA764527B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085368Y2 (ja) * | 1987-03-05 | 1996-02-14 | 日産自動車株式会社 | 内燃機関のコネクティングロッド |
| SI0937075T1 (en) * | 1996-11-11 | 2004-06-30 | Altana Pharma Ag | New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors. |
| SI1392295T1 (sl) | 2001-05-15 | 2006-10-31 | Hoffmann La Roche | Derivati oksazola, substituirani s karboksilno kislino, za uporabo kot ppar -alfa in -gama aktivatorji pri zdravljenju diabetesa |
| ATE445838T1 (de) | 2001-07-25 | 2009-10-15 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| CA2490152C (en) * | 2002-07-03 | 2009-04-07 | F. Hoffmann-La Roche Ag | Oxazole derivatives and their use as insulin sensitizers |
| CA2495942C (en) * | 2002-08-30 | 2010-03-23 | F. Hoffmann-La Roche Ag | Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
| ATE345340T1 (de) * | 2002-09-12 | 2006-12-15 | Hoffmann La Roche | N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis |
| RU2315767C2 (ru) * | 2002-11-25 | 2008-01-27 | Ф.Хоффманн-Ля Рош Аг | Индолилпроизводные, способ их получения, фармацевтическая композиция, способ лечения и/или профилактики заболеваний |
| DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
| WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| ES2728225T3 (es) | 2009-02-20 | 2019-10-23 | 2 Bbb Medicines B V | Sistema de administración de fármacos a base de glutatión |
| US8445002B2 (en) | 2009-05-06 | 2013-05-21 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3935195A (en) * | 1969-04-28 | 1976-01-27 | Sterling Drug Inc. | 4,4'-Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby |
| FR2148362A1 (en) * | 1971-08-11 | 1973-03-23 | Ferlux | 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity |
| AR208500A1 (es) * | 1972-06-14 | 1977-02-15 | Merck & Co Inc | Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas |
-
1975
- 1975-07-29 US US05/600,169 patent/US4011326A/en not_active Expired - Lifetime
-
1976
- 1976-07-14 NL NL7607794A patent/NL7607794A/xx not_active Application Discontinuation
- 1976-07-14 SE SE7608037A patent/SE431545B/xx not_active IP Right Cessation
- 1976-07-15 DK DK320276A patent/DK320276A/da not_active Application Discontinuation
- 1976-07-20 AU AU16052/76A patent/AU505159B2/en not_active Expired
- 1976-07-22 FR FR7622378A patent/FR2319354A1/fr active Granted
- 1976-07-23 CH CH947876A patent/CH603661A5/xx not_active IP Right Cessation
- 1976-07-26 GB GB31065/76A patent/GB1497985A/en not_active Expired
- 1976-07-28 DE DE19762633905 patent/DE2633905A1/de not_active Ceased
- 1976-07-28 HU HU76ME00002006A patent/HU172167B/hu unknown
- 1976-07-28 BE BE169289A patent/BE844577A/xx not_active IP Right Cessation
- 1976-07-28 ZA ZA00764527A patent/ZA764527B/xx unknown
- 1976-07-28 ES ES450245A patent/ES450245A1/es not_active Expired
- 1976-07-29 JP JP51089756A patent/JPS6037116B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU1605276A (en) | 1978-01-26 |
| FR2319354B1 (da) | 1979-07-20 |
| JPS5217495A (en) | 1977-02-09 |
| US4011326A (en) | 1977-03-08 |
| NL7607794A (nl) | 1977-02-01 |
| SE431545B (sv) | 1984-02-13 |
| DE2633905A1 (de) | 1977-02-17 |
| JPS6037116B2 (ja) | 1985-08-24 |
| CH603661A5 (da) | 1978-08-31 |
| ES450245A1 (es) | 1979-05-16 |
| ZA764527B (en) | 1978-03-29 |
| GB1497985A (en) | 1978-01-12 |
| FR2319354A1 (fr) | 1977-02-25 |
| BE844577A (fr) | 1977-01-28 |
| AU505159B2 (en) | 1979-11-08 |
| SE7608037L (sv) | 1977-01-30 |
| HU172167B (hu) | 1978-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK148907C (da) | Analogifremgangsmaade til fremstilling af dihydrocyclosporin c | |
| DK149107C (da) | Analogifremgangsmaade til fremstilling af quinazolonderivater | |
| DK151013C (da) | Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider | |
| DK156776A (da) | Fremgangsmade til fremstilling af carbostyrilderivater | |
| DK146205C (da) | Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater | |
| DK320276A (da) | Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner | |
| DK107876A (da) | Fremgangsmade til fremstilling af thiocarbamider | |
| DK528976A (da) | Fremgangsmade til fremstilling af indazolderivater | |
| DK324176A (da) | Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater | |
| DK148139C (da) | Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater | |
| DK387876A (da) | Fremgangsmade til fremstilling af oxazolidinoner | |
| DK433076A (da) | Fremgangsmade til fremstilling af basisk substituerede pyridincarboxamider | |
| DK383476A (da) | Fremgangsmade til fremstilling af 2-substitueret benzanilid | |
| DK146629C (da) | Analogifremgangsmaade til fremstilling af depotsteroidestere | |
| DK137275C (da) | Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater | |
| DK565676A (da) | Fremgangsmade til fremstilling af klavamderivater | |
| DK137957B (da) | Analogifremgangsmåde til fremstilling af 2-substituerede 5-fluorpyrimidin-4-oner. | |
| DK127976A (da) | Fremgangsmade til fremstilling af thiazolinonderivater | |
| DK551076A (da) | Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin | |
| DK343976A (da) | Fremgangsmade til fremstilling af 5-androsten-17-on-derivater | |
| DK253676A (da) | Fremgangsmade til fremstilling af cycloheptathiopenderivater | |
| DK251176A (da) | Fremgangsmade til fremstilling af cyklopropanolderivater | |
| DK162976A (da) | Fremgangsmade til fremstilling af heterocycliske forbindelser | |
| DK142845C (da) | Analogifremgangsmaade til fremstilling af imidazolderivater | |
| DK141532C (da) | Fremgangsmaade til fremstilling af 21-hydroxy-16-pregnen-20-onderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |